학술논문

Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling.
Document Type
journal article
Source
Annals of the Rheumatic Diseases; Apr2020, Vol. 79 Issue 4, p481-489, 9p, 2 Color Photographs, 1 Black and White Photograph
Subject
BLOCKING antibodies
BIOLOGICAL models
RESEARCH
SYNOVIAL membranes
FIBROBLASTS
DIMERIZATION
ANIMAL experimentation
BIOLOGICAL transport
RESEARCH methodology
CELL receptors
INTERLEUKIN-1
PROTEOLYTIC enzymes
EVALUATION research
MEDICAL cooperation
CELLULAR signal transduction
LEG
GLYCOSAMINOGLYCANS
COMPARATIVE studies
RHEUMATOID arthritis
GLYCOPROTEINS
TRANSFERASES
CELLS
TUMOR necrosis factors
OSTEOARTHRITIS
RESEARCH funding
GENETIC techniques
MICE
PHOSPHORYLATION
CHEMICAL inhibitors
Language
ISSN
00034967
Abstract
Copyright of Annals of the Rheumatic Diseases is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)